Clinical and epidemiological characterization of severe Plasmodium vivax malaria in Gujarat, India
The mounting evidence supporting the capacity of Plasmodium vivax to cause severe disease has prompted the need for a better characterization of the resulting clinical complications. India is making progress with reducing malaria, but epidemics of severe vivax malaria in Gujarat, one of the main con...
Guardado en:
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Taylor & Francis Group
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e7d24da3b2d949c19350cec0f8c913d2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:e7d24da3b2d949c19350cec0f8c913d2 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:e7d24da3b2d949c19350cec0f8c913d22021-11-17T14:21:58ZClinical and epidemiological characterization of severe Plasmodium vivax malaria in Gujarat, India2150-55942150-560810.1080/21505594.2020.1773107https://doaj.org/article/e7d24da3b2d949c19350cec0f8c913d22020-12-01T00:00:00Zhttp://dx.doi.org/10.1080/21505594.2020.1773107https://doaj.org/toc/2150-5594https://doaj.org/toc/2150-5608The mounting evidence supporting the capacity of Plasmodium vivax to cause severe disease has prompted the need for a better characterization of the resulting clinical complications. India is making progress with reducing malaria, but epidemics of severe vivax malaria in Gujarat, one of the main contributors to the vivax malaria burden in the country, have been reported recently and may be the result of a decrease in transmission and immune development. Over a period of one year, we enrolled severe malaria patients admitted at the Civil Hospital in Ahmedabad, the largest city in Gujarat, to investigate the morbidity of severe vivax malaria compared to severe falciparum malaria. Patients were submitted to standard thorough clinical and laboratory investigations and only PCR-confirmed infections were selected for the present study. Severevivax malaria (30 patients) was more frequent than severe falciparum malaria (8 patients) in our setting, and it predominantly affected adults (median age 32 years, interquartile range 22.5 years). This suggests a potential age shift in anti-malarial immunity, likely to result from the recent decrease in transmission across India. The clinical presentation of severe vivax patients was in line with previous reports, with jaundice as the most common complication. Our findings further support the need for epidemiological studies combining clinical characterization of severe vivax malaria and serological evaluation of exposure markers to monitor the impact of elimination programmes.Anupkumar R. AnvikarAnna Maria van EijkAsha ShahKamlesh J. UpadhyaySteven A. SullivanAnkita J. PatelJaykumar M. JoshiSuchi TyagiRanvir SinghJane M. CarltonHimanshu GuptaSamuel C. WassmerTaylor & Francis Grouparticlesevere malariaplasmodium vivaxgujaratindiamalaria eliminationInfectious and parasitic diseasesRC109-216ENVirulence, Vol 11, Iss 1, Pp 730-738 (2020) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
severe malaria plasmodium vivax gujarat india malaria elimination Infectious and parasitic diseases RC109-216 |
spellingShingle |
severe malaria plasmodium vivax gujarat india malaria elimination Infectious and parasitic diseases RC109-216 Anupkumar R. Anvikar Anna Maria van Eijk Asha Shah Kamlesh J. Upadhyay Steven A. Sullivan Ankita J. Patel Jaykumar M. Joshi Suchi Tyagi Ranvir Singh Jane M. Carlton Himanshu Gupta Samuel C. Wassmer Clinical and epidemiological characterization of severe Plasmodium vivax malaria in Gujarat, India |
description |
The mounting evidence supporting the capacity of Plasmodium vivax to cause severe disease has prompted the need for a better characterization of the resulting clinical complications. India is making progress with reducing malaria, but epidemics of severe vivax malaria in Gujarat, one of the main contributors to the vivax malaria burden in the country, have been reported recently and may be the result of a decrease in transmission and immune development. Over a period of one year, we enrolled severe malaria patients admitted at the Civil Hospital in Ahmedabad, the largest city in Gujarat, to investigate the morbidity of severe vivax malaria compared to severe falciparum malaria. Patients were submitted to standard thorough clinical and laboratory investigations and only PCR-confirmed infections were selected for the present study. Severevivax malaria (30 patients) was more frequent than severe falciparum malaria (8 patients) in our setting, and it predominantly affected adults (median age 32 years, interquartile range 22.5 years). This suggests a potential age shift in anti-malarial immunity, likely to result from the recent decrease in transmission across India. The clinical presentation of severe vivax patients was in line with previous reports, with jaundice as the most common complication. Our findings further support the need for epidemiological studies combining clinical characterization of severe vivax malaria and serological evaluation of exposure markers to monitor the impact of elimination programmes. |
format |
article |
author |
Anupkumar R. Anvikar Anna Maria van Eijk Asha Shah Kamlesh J. Upadhyay Steven A. Sullivan Ankita J. Patel Jaykumar M. Joshi Suchi Tyagi Ranvir Singh Jane M. Carlton Himanshu Gupta Samuel C. Wassmer |
author_facet |
Anupkumar R. Anvikar Anna Maria van Eijk Asha Shah Kamlesh J. Upadhyay Steven A. Sullivan Ankita J. Patel Jaykumar M. Joshi Suchi Tyagi Ranvir Singh Jane M. Carlton Himanshu Gupta Samuel C. Wassmer |
author_sort |
Anupkumar R. Anvikar |
title |
Clinical and epidemiological characterization of severe Plasmodium vivax malaria in Gujarat, India |
title_short |
Clinical and epidemiological characterization of severe Plasmodium vivax malaria in Gujarat, India |
title_full |
Clinical and epidemiological characterization of severe Plasmodium vivax malaria in Gujarat, India |
title_fullStr |
Clinical and epidemiological characterization of severe Plasmodium vivax malaria in Gujarat, India |
title_full_unstemmed |
Clinical and epidemiological characterization of severe Plasmodium vivax malaria in Gujarat, India |
title_sort |
clinical and epidemiological characterization of severe plasmodium vivax malaria in gujarat, india |
publisher |
Taylor & Francis Group |
publishDate |
2020 |
url |
https://doaj.org/article/e7d24da3b2d949c19350cec0f8c913d2 |
work_keys_str_mv |
AT anupkumarranvikar clinicalandepidemiologicalcharacterizationofsevereplasmodiumvivaxmalariaingujaratindia AT annamariavaneijk clinicalandepidemiologicalcharacterizationofsevereplasmodiumvivaxmalariaingujaratindia AT ashashah clinicalandepidemiologicalcharacterizationofsevereplasmodiumvivaxmalariaingujaratindia AT kamleshjupadhyay clinicalandepidemiologicalcharacterizationofsevereplasmodiumvivaxmalariaingujaratindia AT stevenasullivan clinicalandepidemiologicalcharacterizationofsevereplasmodiumvivaxmalariaingujaratindia AT ankitajpatel clinicalandepidemiologicalcharacterizationofsevereplasmodiumvivaxmalariaingujaratindia AT jaykumarmjoshi clinicalandepidemiologicalcharacterizationofsevereplasmodiumvivaxmalariaingujaratindia AT suchityagi clinicalandepidemiologicalcharacterizationofsevereplasmodiumvivaxmalariaingujaratindia AT ranvirsingh clinicalandepidemiologicalcharacterizationofsevereplasmodiumvivaxmalariaingujaratindia AT janemcarlton clinicalandepidemiologicalcharacterizationofsevereplasmodiumvivaxmalariaingujaratindia AT himanshugupta clinicalandepidemiologicalcharacterizationofsevereplasmodiumvivaxmalariaingujaratindia AT samuelcwassmer clinicalandepidemiologicalcharacterizationofsevereplasmodiumvivaxmalariaingujaratindia |
_version_ |
1718425517388988416 |